ECE2023 Eposter Presentations Reproductive and Developmental Endocrinology (48 abstracts)
Individuals treated for gender dysphoria with medical and/or surgical transition who subsequently detransitioned: a survey of 7 detransitioners
Emilia Gomez Hoyos 1 , Esther Delgado Garcia 1 , Cristina Mercedes Catalina Fernandez 2 , Carmen Rodriguez Fernandez 2 , Maria Antonia Maniega Rubio 2 , Laura Cuadrado Clemente 3 , Rebeca Jimenez Sahagun 1 , Maria Jose Bartolome Albistegui 4 , Ana Ortolá Buigues 1 & Daniel De Luis Roman 1
1Hospital Clinico Universitario de Valladolid, Endocrinology and Nutrition, Valladolid, Spain; 2Hospital Clinico Universitario de Valladolid, Mental Health, Valladolid, Spain; 3Hospital Universitario Doctor Peset, Endocrinology, Spain; 4Hospital Clinico Universitario de Valladolid, Pediatrics, Valladolid, Spain
Introduction: Detransition is the act of stopping or reversing a gender medical, social or surgical transition. The study’s purpose was to describe our experience with a group of transsexual people in detransition phase.
Material and methods: A cohort of 204 people with gender incongruence attending the Identity Gender Unit Hospital Clinico of Valladolid from January 2014 to December 2022 was studied. Seven of those participants detransitioned and were asked for their reasons, gender identity in detransition phase, and which social, medical, and surgical steps they took to detransition.
Results: Seven detransitioners were natal male. At the beginning of the detransition the age was 24[14-43] years and at started transition was 17[15-19] years. They remained transicioned for a duration of 2 [1-29] years. Most (6/7) had transitioned both medically and socially. Three also had surgical transition (mammoplasty). Mental health diagnoses before the onset of transition was: Anxiety (1/7), Eating disorders (1/7), Autism spectrum disorders (2/7). The mayority (4/7) received an adequate evaluation from mental health professional before starting transition and psychological support during transition. Reasons for destransition included: change in gender identity (3/7), satisfied (1/7) and dissatisfied (1/7) by the physical results of the transition, exploring alternative non-medicalised ways of living their identities and bodies (2/7). Nearly all participants medically detransitioned by ceasing cross-sex hormones (6/7). At the time of detransition 4/7 maintain a female gender identity and reports no gender dysphoria. Only two detransitioners were dissatisfied with their decision to transition and five were satisfied with their decision to detransition.
Conclusion: There are many different reasons and experiences leading to detransition. Medical detransition following the reaffirmation of a transgender identity is not uncommon. Comprehensive care by a multidisciplinary and experienced team is essential.
Article tools
My recent searches
My recently viewed abstracts
Authors
Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2024 |
Privacy policy |
Cookie settings
BiosciAbstracts
Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.
Find out more